je.st
news
Teva to return rights to experimental cancer therapy
2014-12-30 17:21:14| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd. is returning to OncoGenex the rights to a cancer drug, on which the companies had previously collaborated. Under the terms of an initial agreement, Teva will make a $27 million to OncoGenex of Bothell, Wash.
Tags: rights
return
cancer
experimental
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||